- Home
- PDM vs VALN Comparison
PDM vs VALN Comparison
Compare PDM & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDM
- VALN
- Stock Information
- Founded
- PDM 1997
- VALN 2012
- Country
- PDM United States
- VALN France
- Employees
- PDM N/A
- VALN N/A
- Industry
- PDM Building operators
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PDM Real Estate
- VALN Health Care
- Exchange
- PDM Nasdaq
- VALN Nasdaq
- Market Cap
- PDM 1.0B
- VALN 820.0M
- IPO Year
- PDM N/A
- VALN 2021
- Fundamental
- Price
- PDM $8.44
- VALN $8.92
- Analyst Decision
- PDM Buy
- VALN Strong Buy
- Analyst Count
- PDM 4
- VALN 4
- Target Price
- PDM $9.25
- VALN $15.75
- AVG Volume (30 Days)
- PDM 758.4K
- VALN 19.3K
- Earning Date
- PDM 10-27-2025
- VALN 11-20-2025
- Dividend Yield
- PDM 1.50%
- VALN N/A
- EPS Growth
- PDM N/A
- VALN N/A
- EPS
- PDM N/A
- VALN N/A
- Revenue
- PDM $565,372,000.00
- VALN $211,089,992.00
- Revenue This Year
- PDM N/A
- VALN $6.86
- Revenue Next Year
- PDM N/A
- VALN $11.85
- P/E Ratio
- PDM N/A
- VALN N/A
- Revenue Growth
- PDM N/A
- VALN 13.48
- 52 Week Low
- PDM $5.46
- VALN $3.62
- 52 Week High
- PDM $10.02
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- PDM 57.23
- VALN 41.42
- Support Level
- PDM $7.88
- VALN $8.53
- Resistance Level
- PDM $8.36
- VALN $8.92
- Average True Range (ATR)
- PDM 0.24
- VALN 0.25
- MACD
- PDM 0.03
- VALN 0.02
- Stochastic Oscillator
- PDM 85.61
- VALN 31.00
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.